Add like
Add dislike
Add to saved papers

Single plasmid-based, upgradable and backward compatible adenoviral vector systems.

Human Gene Therapy 2019 Februrary 23
Existing adenoviral vector systems have two drawbacks. It is labor-intensive and time-consuming to load a transgene in these systems, and transgene harboring vectors are dead ends: they cannot be reused to construct a vector carrying another transgene or achieving new characteristics. To conquer these shortcomings, we constructed single plasmid-based adenoviral vector systems where a unique PmeI site was located at the position for insertion of exogenous gene. PCR amplified transgene could be cloned into PmeI-linearized start plasmids by one step of Gibson assembly to generate target adenoviral plasmids, which were then ready for virus rescue. This procedure was designated restriction-assembly. To expand the application of these systems, two ClaI sites were created upstream and downstream of the fiber gene to generate an upgraded start plasmid pKAd5f11pABR-EPG. Modified fiber gene, amplified by overlap extension PCR, could be used to substitute original fiber in pKAd5f11pABR-EPG to generate adenoviral plasmid with new fiber by restriction-assembly. On the other hand, pKAd5f11pABR-EPG was also a start adenoviral plasmid for expressing other transgene. In conclusion, we introduced easy-to-use and upgradable adenoviral vector systems here, which offer extensive versatility and can serve as basic platform and functional component library for the synthetic biology of adenoviral vectors.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app